# Arjun Oberoi

> Arjun Oberoi is a Series A investor at Everlife backing Marketing. See 2 investments, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Everlife](https://shizune.co/investors/profile/everlife)
- Total investments: 2
- Last investment: Oct 2021
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/arjun-oberoi-md-6316b28/

Arjun Oberoi is a Managing Director at Everstone Group. He attended The University of Edinburgh.

## Contacts

5 contacts available for Arjun Oberoi: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/arjun-oberoi?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Marketing | 1 | 50% |
| Biotechnology | 1 | 50% |
| Manufacturing | 1 | 50% |
| Medical Device | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Private Equity | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| India | 1 | 50% |
| Singapore | 1 | 50% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AUM Biosciences | AUM Biosciences is an oncology-focused biotechnology company that aims to accelerate the development of innovative, affordable medicines for patients in Asia and around the world. AUM Biosciences focuses on early-stage development of innovative medicines for the treatment of Asian-prevalent cancers. | $27M | Series A | Oct 12, 2021 | https://www.aumbiosciences.com/ |
| Translumina Therapeutics | Translumina Therapeutics is a manufacturing and marketing organization. | $69.9M | Private Equity | Aug 27, 2019 | http://www.translumina.in/ |

2 of 2 investments shown.

## Co-investors
- [SPRIM](https://shizune.co/investors/profile/sprim) — VC Fund, 1 deal together
- [Agency for Science, Technology and Research](https://shizune.co/investors/profile/the-agency-for-science--technology-and-research) — VC Fund, 1 deal together

## About Everlife

VC Fund · Singapore, Singapore

Everlife Asia is a buy-and-build platform aimed to provide complete solutions for the healthcare and research industries.

1 contacts available at Everlife.

| Name | Title | Profile |
| --- | --- | --- |
| Arjun Oberoi | Executive Chairman | https://shizune.co/investors/profile/arjun-oberoi |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Arjun Oberoi invest in?

Arjun Oberoi invests primarily in Marketing, Biotechnology and Manufacturing startups, most often at Series A and Private Equity stage. Most of the 2 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Arjun Oberoi?

Public channels for Arjun Oberoi include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Arjun Oberoi last invest?

The most recent investment recorded for Arjun Oberoi closed in Oct 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co